Actelion (Actelion) Other Stockholders Equity : $-234 Mil (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Other Stockholders Equity?

Actelion's Other Stockholders Equity for the quarter that ended in Mar. 2017 was $-234 Mil.

Actelion's quarterly Other Stockholders Equity increased from Sep. 2016 ($-237 Mil) to Dec. 2016 ($-232 Mil) but then declined from Dec. 2016 ($-232 Mil) to Mar. 2017 ($-234 Mil).

Actelion's annual Other Stockholders Equity declined from Dec. 2014 ($-214 Mil) to Dec. 2015 ($-240 Mil) but then increased from Dec. 2015 ($-240 Mil) to Dec. 2016 ($-232 Mil).

Actelion Other Stockholders Equity Historical Data

The historical data trend for Actelion's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Other Stockholders Equity Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Other Stockholders Equity

Get a 7-Day Free Trial

-216.07

-214.20

-213.79

-239.97

-231.73

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Other Stockholders Equity	Get a 7-Day Free Trial															-239.22	-238.54	-237.17	-231.73	-234.44

Actelion Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Actelion Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Actelion's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (Actelion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson • 08-03-2016

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 01-24-2017

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 02-14-2017

Actelion Still On Growth Track

By reports.droy reports.droy • 02-18-2015